Drawing for WAFERLOGIX

USPTO serial 79377279

WAFERLOGIX

Reviewed by CopyMark Law Group

Reg. 7682981Status 700Registered
Filing date
Status date
Registration date
Feb 11, 2025
Examiner
FEDERICO, EVAN G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WAFERLOGIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Theodore R. Remaklus

Theodore R. Remaklus Thompson Hine LLP312 Walnut Street, Suite 2000Suite 2800Cincinnati, OH 45202-4024

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and nutraceutical preparations for therapeutic or medical purposes in the form of dissolvable wafers that facilitate the delivery of a wide variety of pharmaceutical and nutraceutical actives for the treatment of viral diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, gastrointestinal diseases, endocrine and metabolic diseases, autoimmune diseases, cancer, genetic disorders, musculoskeletal diseases, renal (kidney) diseases, skin diseases, haematological diseases, psychiatric disorders, immunodeficiency disorders, eye and ear disorders, reproductive and gynaecological diseases, oral and dental diseases, allergic diseases, rare and orphan diseases, nutritional diseases, rheumatic diseases, vascular diseases, liver diseases, urinary tract diseases, and sleep disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 27, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 27, 2025FIMPFINAL DISPOSITION PROCESSED—
May 11, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 8, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 22, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 22, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 24, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 24, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 2, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 2, 2024DOCKASSIGNED TO EXAMINER—
Oct 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 30, 2024RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED—
Jul 30, 2024RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED—
Jul 30, 2024RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED—
Jul 3, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 3, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 3, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 11, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 11, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 11, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 8, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 25, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 25, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 12, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 12, 2024RFRRREFUSAL PROCESSED BY MPU—
Mar 26, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 25, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2024DOCKASSIGNED TO EXAMINER—
Aug 29, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 25, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 24, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance